A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease
Clinical trial NCT02679014 · COMPLETED
Trial details
- NCT number
- NCT02679014
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-06
- Primary completion
- 2016-08-28
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.